NO20023015L - Humant heparanasebeslektet polypeptid og nukleinsyre - Google Patents

Humant heparanasebeslektet polypeptid og nukleinsyre

Info

Publication number
NO20023015L
NO20023015L NO20023015A NO20023015A NO20023015L NO 20023015 L NO20023015 L NO 20023015L NO 20023015 A NO20023015 A NO 20023015A NO 20023015 A NO20023015 A NO 20023015A NO 20023015 L NO20023015 L NO 20023015L
Authority
NO
Norway
Prior art keywords
nucleic acid
related polypeptide
human heparanase
heparanase
human
Prior art date
Application number
NO20023015A
Other languages
English (en)
Other versions
NO20023015D0 (no
Inventor
Gerhard Siemeister
Bertram Weiss
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20023015L publication Critical patent/NO20023015L/no
Publication of NO20023015D0 publication Critical patent/NO20023015D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01166—Heparanase (3.2.1.166)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01139—Alpha-glucuronidase (3.2.1.139)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20023015A 1999-12-23 2002-06-21 Humant heparanasebeslektet polypeptid og nukleinsyre NO20023015D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99125831 1999-12-23
PCT/EP2000/012909 WO2001048161A2 (en) 1999-12-23 2000-12-18 Human heparanase-related polypeptide and nucleic acid

Publications (2)

Publication Number Publication Date
NO20023015L true NO20023015L (no) 2002-06-21
NO20023015D0 NO20023015D0 (no) 2002-06-21

Family

ID=8239724

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023015A NO20023015D0 (no) 1999-12-23 2002-06-21 Humant heparanasebeslektet polypeptid og nukleinsyre

Country Status (20)

Country Link
US (1) US20040161745A1 (no)
EP (1) EP1244778A2 (no)
JP (1) JP2003518381A (no)
KR (1) KR20020062375A (no)
CN (1) CN1413249A (no)
AU (1) AU3013901A (no)
BG (1) BG106842A (no)
BR (1) BR0016703A (no)
CA (1) CA2392703A1 (no)
CZ (1) CZ20022147A3 (no)
EE (1) EE200200353A (no)
HU (1) HUP0203724A2 (no)
IL (1) IL149506A0 (no)
MX (1) MXPA02005077A (no)
NO (1) NO20023015D0 (no)
PL (1) PL362867A1 (no)
RU (1) RU2002119561A (no)
SK (1) SK8882002A3 (no)
WO (1) WO2001048161A2 (no)
ZA (1) ZA200205852B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072973A2 (en) * 2000-02-24 2001-10-04 Bayer Aktiengesellschaft Regulation of human heparanase-like enzyme
GB0008912D0 (en) * 2000-04-11 2000-05-31 Janssen Pharmaceutica Nv Mammalian heparanase
US20040171535A1 (en) * 2000-04-20 2004-09-02 Heinrikson Robert Leroy Heparanase II, a novel human heparanase paralog
AU2001287610A1 (en) * 2000-07-12 2002-01-21 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A second human heparanase, and splice variants thereof, with a predominant expression in skeletal muscle, heart and pancreas
FR2818131B1 (fr) * 2000-12-14 2005-02-11 Oreal Composition cosmetique comprenant de l'heparanase
CN101311188B (zh) * 2007-05-21 2010-12-29 中国人民解放军军事医学科学院生物工程研究所 人乙酰肝素酶的小分子多肽抑制剂
CN101670115B (zh) * 2009-07-31 2011-07-27 中国人民解放军第三军医大学 乙酰肝素酶与热休克蛋白的复合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
WO1999021975A1 (en) * 1997-10-28 1999-05-06 The Australian National University Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
CN1370178A (zh) * 1999-06-25 2002-09-18 洞察战略及销售有限公司 多核苷酸及其编码的与乙酰肝素酶同源较远的多肽
CA2387695A1 (en) * 1999-09-23 2001-03-29 Klaus Ducker A novel member of the heparanase protein family

Also Published As

Publication number Publication date
HUP0203724A2 (hu) 2003-03-28
AU3013901A (en) 2001-07-09
WO2001048161A2 (en) 2001-07-05
WO2001048161A3 (en) 2002-02-14
EP1244778A2 (en) 2002-10-02
PL362867A1 (en) 2004-11-02
EE200200353A (et) 2003-10-15
KR20020062375A (ko) 2002-07-25
SK8882002A3 (en) 2002-11-06
CN1413249A (zh) 2003-04-23
JP2003518381A (ja) 2003-06-10
US20040161745A1 (en) 2004-08-19
CA2392703A1 (en) 2001-07-05
ZA200205852B (en) 2003-10-22
BR0016703A (pt) 2002-09-24
MXPA02005077A (es) 2002-11-07
RU2002119561A (ru) 2004-02-10
NO20023015D0 (no) 2002-06-21
IL149506A0 (en) 2002-11-10
CZ20022147A3 (cs) 2002-09-11
BG106842A (en) 2003-05-30

Similar Documents

Publication Publication Date Title
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
DK1163271T3 (da) Rekombinant IL-18 antistoffer og deres anvendelse
NO993619D0 (no) Titandioksid, fremstilling og anvendelse derav
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO20023015L (no) Humant heparanasebeslektet polypeptid og nukleinsyre
NO990300D0 (no) <Alfa>-aminosyreamider, fremstilling og terapeutisk anvendelse derav
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
DE69837507D1 (de) Humanes Hedgehog-Protein
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
EP1239039A4 (en) NEW POLYPEPTIDE AND ENCODING DNA
NO20020919L (no) Irenprotein, dets fremstilling og anvendelse
HUP0201660A2 (en) Novel polypeptide and dna thereof
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
NO991227D0 (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
DK1216021T3 (da) Farmaceutiske og/eller kosmetiske præparater
NO990303L (no) Lipidbindende proteiner og deres terapeutiske og diagnostiske anvendelse
NO20006091D0 (no) Humant protein C-polypeptid
NO20015906L (no) Spleisosomprotein og dets anvendelse
DK1897947T3 (da) IL-17-homologe polypeptider og terapeutiske anvendelser deraf
NO955325L (no) Propansyrederivater, deres fremstilling og terapeutiske anvendelse
DK1283215T3 (da) Secerneret polypeptid og nucleinsyrer kodende derfor
EP1234032A4 (en) NUCLEIC ACID AND POLYPEPTIDE
NO20014300D0 (no) Nytt protein og dets anvendelse
DE69939345D1 (de) Neuartiges polypeptid und dessen kodierende nukleinsäuren
ATE404576T1 (de) Neuartiges polypeptid und dessen kodierende nukleinsäuren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application